Insilico's Lung Drug Reverses Aging Markers in Study

Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.